{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T09:49:04Z","timestamp":1782294544522,"version":"3.54.5"},"reference-count":24,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2008,2,24]],"date-time":"2008-02-24T00:00:00Z","timestamp":1203811200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2008,2,24]],"date-time":"2008-02-24T00:00:00Z","timestamp":1203811200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Science"],"published-print":{"date-parts":[[2008,5]]},"abstract":"<jats:p>\n                    Causing damage to angiogenic vessels is a promising approach for cancer chemotherapy. The present study is a codification of a designed liposomal drug delivery system (DDS) for antineovascular therapy (ANET) with 2\u2032\u2010\n                    <jats:italic>C<\/jats:italic>\n                    \u2010cyano\u20102\u2032\u2010deoxy\u20101\u2010\u03b2\u2010D\u2010\n                    <jats:italic>arabino<\/jats:italic>\n                    \u2010pentofuranosylcytosine (CNDAC). The authors have previously reported that liposomalized 5\u2032\u2010\n                    <jats:italic>O<\/jats:italic>\n                    \u2010dipalmitoylphosphatidyl CNDAC (DPP\u2013CNDAC), a phospholipid derivative of the novel antitumor nucleoside CNDAC, is quite useful for ANET. DPP\u2013CNDAC liposomes modified with APRPG, a peptide having affinity toward angiogenic vessels, efficiently suppressed tumor growth by damaging angiogenic endothelial cells. In the present study, the authors masked the hydrophilic moiety of DPP\u2013CNDAC, namely, CNDAC, on the liposomal surface with APRPG\u2013polyethyleneglycol (PEG) conjugate to improve the availability of DPP\u2013CNDAC liposomes. The use of the APRPG\u2013PEG conjugate attenuated the negative \u03b6\u2010potential of the DPP\u2013CNDAC liposomes and reduced the agglutinability of them in the presence of serum. These effects improved the blood level of DPP\u2013CNDAC liposomes in colon 26 NL\u201017 tumor\u2010bearing BALB\/c male mice, resulting in enhanced accumulation of them in the tumor. Laser scanning microscopic observations indicated that APRPG\u2013PEG\u2010modified DPP\u2013CNDAC liposomes (LipCNDAC\/APRPG\u2013PEG) colocalized with angiogenic vessels and strongly induced apoptosis of tumor cells, whereas PEG\u2010modified DPP\u2013CNDAC liposomes (LipCNDAC\/PEG) did not. In fact, LipCNDAC\/APRPG\u2013PEG suppressed the tumor growth more strongly compared to LipCNDAC\/PEG and increased significantly the life span of the mice. The present study is a good example of an effective liposomal DDS for ANET that is characterized by: (i) phospholipid derivatization of a certain anticancer drug to suit the liposomal formulation; (ii) PEG\u2010shielding for masking undesirable properties of the drug on the liposomal surface; and (iii) active targeting to angiogenic endothelial cells using a specific probe. (\n                    <jats:italic>Cancer Sci<\/jats:italic>\n                    2008; 99: 1029\u20131033)\n                  <\/jats:p>","DOI":"10.1111\/j.1349-7006.2008.00758.x","type":"journal-article","created":{"date-parts":[[2008,2,24]],"date-time":"2008-02-24T14:14:15Z","timestamp":1203862455000},"page":"1029-1033","source":"Crossref","is-referenced-by-count":19,"title":["Antineovascular therapy with angiogenic vessel\u2010targeted polyethyleneglycol\u2010shielded liposomal DPP\u2013CNDAC"],"prefix":"10.1111","volume":"99","author":[{"given":"Tomohiro","family":"Asai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souichiro","family":"Miyazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Hatanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasufumi","family":"Katanasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Shuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Oku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,2,24]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.2174\/1566524033479465"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81683-9"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2003.12.015"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.9.1.63"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(05)91009-4"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205347"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(01)03265-3"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(90)81016-H"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/380561a0"},{"key":"e_1_2_7_11_2","first-page":"3743","article-title":"Doxorubicin encapsulated in sterically stabilized liposomes is superior to free drug or drug\u2010containing conventional liposomes at suppressing growth and metastases of human lung tumor xenografts","volume":"56","author":"Sakakibara T","year":"1996","journal-title":"Cancer Res"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(02)00075-3"},{"key":"e_1_2_7_13_2","first-page":"6387","article-title":"A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS","volume":"46","author":"Matsumura Y","year":"1986","journal-title":"Cancer Res"},{"key":"e_1_2_7_14_2","first-page":"7","article-title":"Doxorubicin\u2010polymer conjugates. Further demonstration of the concept of enhanced permeability and retention","volume":"5","author":"Muggia F.","year":"1999","journal-title":"Clin Cancer Res"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2003.11.073"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2004.07.033"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.29.1936"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00113a034"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-006-5392-0"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-006-8219-0"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0960-894X(96)00162-X"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.21.766"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(00)00633-9"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(02)02821-1"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910580318"}],"container-title":["Cancer Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1349-7006.2008.00758.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1349-7006.2008.00758.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/j.1349-7006.2008.00758.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1349-7006.2008.00758.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T09:27:35Z","timestamp":1782293255000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1349-7006.2008.00758.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,24]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["10.1111\/j.1349-7006.2008.00758.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1349-7006.2008.00758.x","archive":["Portico"],"relation":{},"ISSN":["1347-9032","1349-7006"],"issn-type":[{"value":"1347-9032","type":"print"},{"value":"1349-7006","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,24]]}}}